AndroGel Cost in Mississippi 2026: Cash Price, Insurance, Medicaid, and Cheaper Alternatives

Prescription access and medication affordability image for AndroGel Cost in Mississippi 2026: Cash Price, Insurance, Medicaid, and Cheaper Alternatives

At a glance

  • Brand name / AndroGel (AbbVie), testosterone 1% and 1.62% topical gel
  • AbbVie list price / ~$510 per month in 2026
  • Typical compounded alternative / $80, $120 per month via Mississippi 503A pharmacy
  • Mississippi Medicaid coverage / Not covered for testosterone gel
  • AbbVie savings card / $0 co-pay for eligible commercially insured patients
  • Prior authorization required / Yes, for most Mississippi private insurance plans
  • Telehealth prescribing / Legal in Mississippi
  • 503A compounding / Legal in Mississippi for testosterone gel
  • FDA approval status / Approved for male hypogonadism (accessdata.fda.gov)
  • Once-daily dosing / Apply to shoulders, upper arms, or abdomen

What Does AndroGel Actually Cost in Mississippi in 2026?

The cash-pay price for AndroGel at most Mississippi retail pharmacies sits at approximately $510 per month in 2026, a figure consistent with AbbVie's published list price. That number assumes no insurance, no manufacturer coupon, and no third-party discount card. For many Mississippi men, that price is simply not affordable on a standing monthly basis.

The branded product comes in two concentrations: testosterone 1% gel (the original formulation approved by the FDA) and testosterone 1.62% gel (the higher-concentration formulation that requires smaller application volumes). Both are dispensed as metered-dose pumps or individual unit-dose packets. The FDA-approved prescribing information for AndroGel specifies a starting dose of 50 mg testosterone (five grams of the 1% gel) applied once daily, with titration guided by serum testosterone levels measured 14 days after initiation.

Prices vary modestly across Mississippi by pharmacy chain. GoodRx and RxSaver coupons can reduce the out-of-pocket cost to roughly $390 to $430 per month at high-volume retailers such as Walmart, Kroger, or CVS in Jackson, Hattiesburg, or Gulfport. That still represents a substantial annual expense of $4,680 to $5,160, which is why understanding all available cost-reduction tools matters before filling a first prescription.


Does Mississippi Medicaid Cover AndroGel?

Mississippi Medicaid does not cover AndroGel or any brand-name testosterone gel as of 2026. The Mississippi Division of Medicaid's preferred drug list (PDL) excludes AndroGel from its covered formulary for testosterone replacement therapy. Generic testosterone gel formulations have limited preferred status, but even generic coverage carries restrictions tied to a confirmed diagnosis of primary or secondary hypogonadism supported by two morning serum testosterone measurements below 300 ng/dL, taken on separate days.

Testosterone replacement therapy is medically indicated for men with documented hypogonadism. The Endocrine Society's 2018 Clinical Practice Guideline states: "We recommend testosterone therapy for men with symptomatic androgen deficiency to induce and maintain secondary sex characteristics and to improve their sexual function, sense of well-being, muscle mass and strength, and bone mineral density." (Endocrine Society Clinical Practice Guideline, 2018)

Despite that clinical backing, Mississippi Medicaid's coverage gap is real. Men enrolled in Medicaid who need testosterone replacement may need to appeal a denial with supporting lab work and physician documentation, pursue a 340B-discounted prescription through a Federally Qualified Health Center (FQHC), or transition to a compounded alternative (discussed below).

Dual-eligible beneficiaries enrolled in both Medicaid and Medicare Part D should check their specific Part D plan formulary. Medicare Part D plans vary in their testosterone coverage, and some do list generic testosterone gel at Tier 2 or Tier 3 with a co-pay below $50 per month.


Which Private Insurance Plans Cover AndroGel in Mississippi?

Most private insurance plans sold in Mississippi cover testosterone therapy in some form, but brand-name AndroGel almost always sits at Tier 3 or Tier 4 on commercial formularies, making prior authorization the standard first hurdle. Blue Cross Blue Shield of Mississippi, Magnolia Health (Centene), and UnitedHealthcare Mississippi all require prior authorization for AndroGel and typically prefer a step-therapy approach: the patient must fail on or be clinically ineligible for generic testosterone gel before the insurer will cover the branded product.

Prior authorization approval generally requires:

  1. Two morning serum testosterone levels below 300 ng/dL drawn at least one week apart.
  2. A confirmed diagnosis of primary hypogonadism (hypergonadotropic) or secondary hypogonadism (hypogonadotropic) documented in the medical record.
  3. A letter of medical necessity from a licensed prescriber.

Once approved, the insurer's negotiated rate typically reduces the member cost-share to $60 to $150 per month depending on plan tier and deductible status. Patients in high-deductible health plans (HDHPs) may pay the full negotiated rate, which can still exceed $300 per month until the deductible is met.

For patients with commercial insurance who are denied, the AbbVie myAbbVie Assist program and the AbbVie savings card (discussed in a dedicated section below) may bring costs below what the insurance co-pay would have been anyway.


How the AbbVie Savings Card Works for Mississippi Patients

AbbVie offers a co-pay savings card for commercially insured patients that, depending on eligibility, can reduce AndroGel co-pay to as low as $0 per month. The program is available at AbbVie's patient assistance portal and does not require income verification for the savings card tier (income verification applies only to the separate myAbbVie Assist free-medication program for uninsured patients below certain income thresholds).

Patients who are uninsured and do not qualify for myAbbVie Assist face the full $510 list price unless they use a GoodRx or similar discount coupon. Those coupons are not stackable with the AbbVie card.

A few practical points for Mississippi patients applying for the savings card:

  • The card is only valid for patients with commercial insurance. Medicare, Medicaid, TRICARE, and VA beneficiaries are not eligible.
  • The card covers up to a specified annual maximum benefit, which AbbVie adjusts periodically. Verify the current annual cap on the AbbVie website before assuming year-round $0 cost-share.
  • Mississippi pharmacies that participate in the program include major chains and most independent pharmacies with AbbVie wholesaler agreements.

Is Compounded Testosterone Gel Legal in Mississippi?

Yes, compounded testosterone gel is legal in Mississippi when prepared by a state-licensed 503A compounding pharmacy operating under the federal Drug Quality and Security Act (DQSA) and Mississippi Board of Pharmacy rules. A 503A pharmacy compounds medications for individual patients based on a valid prescription from a licensed prescriber. That means a physician, nurse practitioner, or physician assistant in Mississippi can write a prescription for testosterone gel in a specific concentration, base, and delivery format that a 503A pharmacy then prepares specifically for that patient.

The legal framework is clear. Under 21 U.S.C. § 503A, pharmacies compounding for individual patients are exempt from FDA new drug approval requirements provided the compounded preparation is not essentially a copy of a commercially available drug, is prepared by a licensed pharmacist or physician, and uses USP-grade active pharmaceutical ingredients. FDA guidance on 503A compounding confirms testosterone is on the FDA's list of bulk drug substances that may be used in compounding under certain conditions.

In practice, most Mississippi 503A compounding pharmacies offer testosterone gel in concentrations ranging from 1% to 20%, often in non-alcohol bases such as Versabase or PLO gel that may produce less skin irritation than the commercial product's alcohol-based carrier. Costs typically run $80 to $120 per month, compared to $510 for branded AndroGel. That price difference, roughly $390 to $430 per month or about $4,700 to $5,160 annually, is why compounded testosterone gel has become the de facto standard for cash-pay TRT patients in Mississippi.

One clinical note: compounded preparations are not FDA-approved, and potency and sterility depend on the compounding pharmacy's quality controls. The American Urological Association's 2022 testosterone guideline advises prescribers to use FDA-approved testosterone formulations when possible, while acknowledging that cost and access barriers may make compounding a reasonable alternative for some patients. Patients choosing compounded testosterone gel should request a certificate of analysis (COA) from the compounding pharmacy confirming active ingredient concentration.


Can You Get a Testosterone Prescription via Telehealth in Mississippi?

Telehealth prescribing of testosterone gel is legal in Mississippi in 2026. A licensed Mississippi prescriber, including those working for telehealth platforms, may order testosterone after obtaining a complete clinical history, reviewing lab results, and conducting a synchronous audio-video consultation that meets Mississippi State Board of Medical Licensure standards for a valid prescriber-patient relationship.

Mississippi adopted permanent telehealth prescribing rules following the COVID-19 public health emergency, removing the prior requirement for an in-person visit before controlled-substance prescribing. Testosterone (as a Schedule III controlled substance under the federal Controlled Substances Act) can be prescribed via telehealth when the prescriber has established an appropriate clinical relationship and documented the diagnostic criteria for hypogonadism.

The practical benefit for Mississippi patients is access. Mississippi has a significant shortage of endocrinologists and urologists outside of the Jackson metro area. Men in rural counties such as Leake, Quitman, or Issaquena historically had to travel 100 to 200 miles for a specialist appointment. Telehealth TRT platforms now allow those patients to receive an initial evaluation, lab order, and prescription within a few days.

The T-Trials, a coordinated set of double-blind, placebo-controlled trials published in the New England Journal of Medicine (N=790 men aged 65 and older with low testosterone), found that testosterone treatment improved sexual function and bone mineral density but not walking distance or vitality at one year. (Snyder et al., NEJM, 2016, PMID 26886521) That evidence base supports careful, diagnosis-confirmed prescribing, regardless of the delivery channel (telehealth or in-person).


Clinical Evidence Supporting Testosterone Gel Therapy

Testosterone gel's efficacy and safety profile in men with hypogonadism rests on a substantial body of evidence accumulated since the FDA approved the 1% formulation in 2000.

The T-Trials (N=790) demonstrated that testosterone treatment for one year produced a mean increase of 60.4 points on the Psychosexual Daily Questionnaire (PDQ) sexual desire domain (P<0.001) compared to placebo, and a statistically significant improvement in bone mineral density at the lumbar spine (+3.5% vs. +1.0% for placebo, P<0.001). (Snyder et al., NEJM, 2016, PMID 26886521)

The TRAVERSE trial (N=5,246 men with hypogonadism and elevated cardiovascular risk), published in 2023 in the New England Journal of Medicine, found that testosterone replacement therapy was non-inferior to placebo for major adverse cardiovascular events (MACE) over a mean follow-up of 33 months, with a MACE rate of 7.0% in the testosterone group versus 7.3% in the placebo group (hazard ratio 0.96 to 95% CI 0.78 to 1.17). (Lincoff et al., NEJM, 2023) That finding addressed a decade of cardiovascular safety concern following earlier observational data.

The Endocrine Society guideline recommends against prescribing testosterone to men with hematocrit above 54%, untreated severe obstructive sleep apnea, uncontrolled heart failure, a myocardial infarction or stroke within the previous six months, or active prostate cancer. These contraindications apply equally to telehealth-prescribed and in-person-prescribed testosterone gel in Mississippi.

HealthRX Mississippi TRT Cost Decision Framework

| Patient Situation | Recommended Cost Path | |---|---| | Commercially insured, prior auth approved | AbbVie savings card, target $0 co-pay | | Commercially insured, prior auth denied | Appeal with step-therapy documentation, then consider compounded gel | | Mississippi Medicaid only | 340B FQHC for generic gel or compounded 503A gel | | Uninsured, income qualifies | myAbbVie Assist (free drug program) | | Uninsured, income does not qualify | Compounded 503A gel ($80, $120/month) or GoodRx on generic testosterone gel | | Medicare Part D | Check formulary tier; generic testosterone gel often at Tier 2 |


Generic Testosterone Gel vs. Brand-Name AndroGel in Mississippi

Generic testosterone gel (1% and 1.62%) has been available in the U.S. since 2015, when Perrigo's authorized generic entered the market following patent expiration. In Mississippi pharmacies, the generic 1% gel costs approximately $120 to $180 per month without insurance, substantially less than the brand but still higher than compounded testosterone gel.

Bioequivalence between the generic and the brand is established by FDA standards (80 to 125% of the reference product's AUC and Cmax). Clinically, the products are interchangeable for most patients. The main practical differences are:

  • Packet size and pump volume may differ slightly between manufacturers.
  • Alcohol content and base excipients vary, which may affect skin tolerability in individual patients.
  • Generic versions do not qualify for the AbbVie savings card, which is brand-specific.

For patients on commercial insurance whose plan covers generic testosterone gel at a Tier 2 co-pay of $30 to $60, the generic is often the most cost-effective branded option. For cash-pay patients, compounded testosterone gel from a Mississippi 503A pharmacy typically undercuts even the generic retail price.


Monitoring Requirements and Ongoing Costs

The prescription cost is not the only expense. Patients on testosterone gel therapy require periodic laboratory monitoring that adds to the total annual outlay. The Endocrine Society recommends checking serum testosterone 14 days after initiation (to verify absorption and guide dose titration), then at 3 months, and annually thereafter once stable. Hematocrit, PSA, and lipid panel checks are standard at baseline, 3 months, and annually.

A standard testosterone panel (total testosterone, free testosterone, LH, FSH, SHBG) at a Mississippi commercial lab runs roughly $50 to $150 depending on the ordering platform. Telehealth TRT companies frequently include lab work in their monthly membership fee, which ranges from $75 to $150 per month and may make the all-in cost of telehealth-prescribed compounded gel ($155 to $270 per month) competitive with in-person-managed branded AndroGel after the AbbVie savings card.

Polycythemia (hematocrit above 54%) is the most common dose-limiting adverse effect of testosterone gel. The TRAVERSE trial reported polycythemia in 4.4% of the testosterone group versus 1.0% of the placebo group. (Lincoff et al., NEJM, 2023) Patients developing elevated hematocrit may require dose reduction, increased monitoring frequency, or therapeutic phlebotomy, all of which add cost.


Practical Steps for Mississippi Patients to Reduce AndroGel Cost

  1. Get a confirmed diagnosis first. Two morning serum testosterone measurements below 300 ng/dL, drawn on separate days before 10 a.m., are required by most Mississippi insurers and by good clinical practice. Skipping this step leads to prior authorization denials.

  2. Ask your prescriber about generic testosterone gel. If your insurance covers generic testosterone gel at a lower tier than AndroGel, the clinical outcome is the same and the co-pay is lower.

  3. Apply for the AbbVie savings card before your first fill. The card must be activated before the prescription is dispensed. Retroactive application is not accepted at most Mississippi pharmacies.

  4. Request a 90-day supply when possible. Most Mississippi retail pharmacies offer a per-unit discount on 90-day fills compared to 30-day fills, and mail-order pharmacy benefit programs through insurance often further reduce the per-unit cost.

  5. Ask about 503A compounding options. A Mississippi-licensed prescriber can write a prescription for compounded testosterone gel, and a 503A pharmacy can fill it. The $80 to $120 monthly cost is roughly 75 to 84% less than branded AndroGel at list price.

  6. Check FQHC options if you are uninsured or on Medicaid. Federally Qualified Health Centers in Mississippi operate under the 340B drug pricing program, which may allow access to discounted testosterone formulations not available through standard retail pharmacies.

  7. Use GoodRx or a similar discount card on generic gel if you pay cash. The generic testosterone 1% gel priced through GoodRx at large Mississippi retailers often falls below $100 per month, making it the cheapest FDA-approved option short of compounding.


Frequently asked questions

How much does AndroGel cost in Mississippi?
The cash-pay price for AndroGel at Mississippi retail pharmacies is approximately $510 per month in 2026, consistent with AbbVie's national list price. GoodRx coupons may reduce that to roughly $390 to $430 at high-volume retailers. Commercially insured patients with the AbbVie savings card may pay as little as $0 per month.
Does Mississippi Medicaid cover AndroGel?
No. Mississippi Medicaid does not cover brand-name AndroGel as of 2026. The state preferred drug list excludes testosterone gel for most indications. Men on Medicaid may explore a 340B-discounted prescription through a Federally Qualified Health Center or consider compounded testosterone gel from a 503A pharmacy.
Is compounded testosterone gel legal in Mississippi?
Yes. A Mississippi-licensed 503A compounding pharmacy can legally prepare testosterone gel for individual patients based on a valid prescription. The FDA permits compounding from bulk testosterone under 21 U.S.C. 503A when the preparation is not a copy of a commercially available product. Costs typically run $80 to $120 per month.
Can I get AndroGel via telehealth in Mississippi?
Yes. Mississippi allows telehealth prescribing of testosterone gel, including Schedule III controlled substances, following permanent rule changes after the COVID-19 public health emergency. A prescriber must establish a valid prescriber-patient relationship via synchronous audio-video consultation and document diagnostic criteria for hypogonadism before writing the prescription.
Which insurance plans cover AndroGel in Mississippi?
Most major Mississippi commercial insurers, including Blue Cross Blue Shield of Mississippi, Magnolia Health, and UnitedHealthcare Mississippi, cover testosterone therapy but require prior authorization for brand-name AndroGel. Coverage typically requires two morning testosterone levels below 300 ng/dL and a documented hypogonadism diagnosis. Brand-name AndroGel usually sits at Tier 3 or Tier 4 on formularies.
What is the cheapest way to get AndroGel in Mississippi?
For cash-pay patients, compounded testosterone gel from a licensed Mississippi 503A pharmacy is generally cheapest at $80 to $120 per month. For commercially insured patients, the AbbVie savings card combined with a prior-authorized Tier 3 fill may reach $0 co-pay. Generic testosterone 1% gel with a GoodRx coupon at a large retailer often costs under $100 per month and is FDA-approved.
Are there Mississippi AndroGel discount programs?
Yes. AbbVie offers two programs: a co-pay savings card for commercially insured patients (target $0 co-pay) and myAbbVie Assist for uninsured or underinsured patients who meet income requirements (free medication). GoodRx, RxSaver, and similar discount card platforms also reduce out-of-pocket cost on both brand and generic testosterone gel at most Mississippi pharmacies.
How does the AbbVie savings card work in Mississippi?
The AbbVie savings card is activated through AbbVie's patient assistance portal before the first prescription fill. Eligible patients must have commercial insurance (Medicare, Medicaid, TRICARE, and VA are excluded). The card covers the difference between the insurance co-pay and $0, up to an annual maximum benefit that AbbVie sets each year. Mississippi pharmacies with AbbVie wholesaler agreements can process the card at the point of sale.

References

  1. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
  2. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37256993/
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
  4. U.S. Food and Drug Administration. AndroGel (testosterone gel) 1% prescribing information. Revised 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021015s042lbl.pdf
  5. U.S. Food and Drug Administration. 503A compounding pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
  6. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://pubmed.ncbi.nlm.nih.gov/20525905/
  7. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
  8. Centers for Medicare and Medicaid Services. Medicaid preferred drug lists and prior authorization. https://www.cdc.gov/